Home | MyCME | All CME | Blog | Psychlopedia



Activities in This Series

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck.

New mechanisms of action present new opportunities to improve outcomes for patients with depression. Listen to a panel of experts discuss best practices and novel antidepressants at the 2019 ASCP Annual Meeting.

Audio Summary
Integrating Novel Antidepressants in MDD Treatment

Integrating Novel Antidepressants in MDD Treatment

1.50 Credits | Rel 07/15/2019 | Exp 07/31/2021